UNSPSC 51292909: Lofepramine

This classification denotes an antidepressant agent with the molecular formula C26H27ClN2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OCA4JT7PAW, chemically known as 5,6-dihydro-n-(3-(dimethylamino)propyl)-11h-dibenz(b,e)azepine but generally known as lofepramine, which bears US NIH Compound Identifier 3696. European Medicines Agency schedules Lofepramine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08557MIG. The term LOFEPRAMINE is an International Non-Proprietary Name.

UNSPSC 51292909 Lofepramine, a Commodity code, does not align with recent state and local procurement activity in the dataset. The single recent opportunity tagged to this code — Seminole County, Florida's IFB 60459723LAS — solicits Naloxone and Safe Drug Deactivation Systems, which fall outside the scope of lofepramine, a tricyclic antidepressant pharmaceutical. State and local governments do procure pharmaceuticals through commodity codes, but the mismatch between the code's stated product and the actual solicitation indicates either a tagging error or minimal relevant recent activity under this specific code.

Seminole County posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The response deadline was July 26, 2023. The procurement requires vendors to submit bids electronically, include all shipping and delivery costs, maintain drug-free workplace certification and E-Verify compliance, and carry workers' compensation, commercial general liability, and professional liability insurance. The contract carries a two-year initial term with a one-year renewal option and includes a three-month probationary period. Because the recent-opportunities block supports no lofepramine-specific solicitations, pursue this code only if your firm supplies pharmaceutical products to county health departments and can address the tagging anomaly directly with the issuing body.